CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas

Circular RNAs (circRNAs) are increasingly recognized as functional non-coding transcripts with oncogenic potential. Here, a comprehensive analysis of circRNA expression in primary ALK(+) anaplastic large-cell lymphoma (ALK( + ) ALCL) is presented. Integrated transcriptomic profiling revealed that aberrant expression of circZBTB46 and of its linear host transcript, normally restricted to dendritic cells, is exclusive to ALK(+) lymphoma cells and driven by the oncogenic NPM1::ALK/STAT3 axis. Functional studies showed that circZBTB46, unlike its protein-coding counterpart, promotes resistance to the ALK inhibitor crizotinib. Silencing circZBTB46 restored crizotinib sensitivity in resistant ALCL cells both in vitro and in vivo. Transcriptomic analyses identified PIP5K1C as a downstream effector regulated through a competitive endogenous RNA mechanism in which circZBTB46 acts as a sponge to miR-25-3p, alleviating its repression of PIP5K1C. These findings uncover a previously unrecognized mechanism of drug resistance in ALK( + ) ALCL and establish circZBTB46 as a promising therapeutic target.

Authors

Institutions

Publication Details

Journal
Leukemia
Published
2026-06-26
DOI
https://doi.org/10.1038/s41375-026-03018-w
Primary Topic
Circular RNAs in diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas

Christine Gaspin, Laurence Lamant, Fabienne Meggetto, Steffen Fuchs et al.
Leukemia
Circular RNAs in diseases
article

CircZBTB46, a promising therapeutic target in crizotinib resistant ALK-positive T lymphomas

Christine Gaspin, Laurence Lamant, Fabienne Meggetto, Steffen Fuchs, Cathy Quelen, Stéphane Pyronnet, Chloé Bessière, Marina Bousquet, Elissa Andraos, Sandra Dailhau, Loélia Babin, Romain Pfeifer, Lola Colras, Iyad Daoudi, Ahmed Zamani, Cindy Pinto
article en

Abstract

Circular RNAs (circRNAs) are increasingly recognized as functional non-coding transcripts with oncogenic potential. Here, a comprehensive analysis of circRNA expression in primary ALK(+) anaplastic large-cell lymphoma (ALK( + ) ALCL) is presented. Integrated transcriptomic profiling revealed that aberrant expression of circZBTB46 and of its linear host transcript, normally restricted to dendritic cells, is exclusive to ALK(+) lymphoma cells and driven by the oncogenic NPM1::ALK/STAT3 axis. Functional studies showed that circZBTB46, unlike its protein-coding counterpart, promotes resistance to the ALK inhibitor crizotinib. Silencing circZBTB46 restored crizotinib sensitivity in resistant ALCL cells both in vitro and in vivo. Transcriptomic analyses identified PIP5K1C as a downstream effector regulated through a competitive endogenous RNA mechanism in which circZBTB46 acts as a sponge to miR-25-3p, alleviating its repression of PIP5K1C. These findings uncover a previously unrecognized mechanism of drug resistance in ALK( + ) ALCL and establish circZBTB46 as a promising therapeutic target.

Leukemia
Centre National de la Recherche Scientifique (FR), Inserm (FR), Humboldt-Universität zu Berlin (DE), Centre de Recherches en Cancérologie de Toulouse (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Génétique Physiologie et Systèmes d'Elevage (FR), Charité - Universitätsmedizin Berlin (DE)
Good health and well-being
Openalex Percentile: Top 11%
Circular RNAs in diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.